This antibody recognises chondroitin sulfate proteoglycan NG2 also known as chondroitin sulfate proteoglycan 4 (CSPG4) and melanoma chondroitin sulfate proteoglycan. It was first characterized in rat as a high-molecular-weight type 1 membrane proteoglycan (Stallcup 1981). CSPG4 is involved in cell attachment and migration. It regulates spreading of melanoma cells by recruiting and activating a signalling cascade through CDC42, ACK1 and p130cas. It enhances FAK and ERK activation.
Applications
WB
Dilutions
WB: 1:500 - 1:2,000
Reactivity
Human
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1950-2210 of human chondroitin sulphate proteoglycan NG2.
Approximately 320 kDa in HeLa and A375 cell lysates under reducing conditions
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% ProClin 300 and 50% Glycerol.
Storage
Store undiluted at -20°C. Storage in frost free freezers is not recommended. Avoid freeze-thaw cycles. Should this product contain a precipitate we recommend microcentrifugation before use.
General Notes
Rabbit anti chondroitin sulphate proteoglycan NG2 antibody recognizes chondroitin sulfate proteoglycan NG2 also known as chondroitin sulfate proteoglycan 4 (CSPG4) and melanoma chondroitin sulfate proteoglycan. It was first characterized in rat as a high-molecular-weight type 1 membrane proteoglycan (Stallcup 1981). CSPG4 is involved in cell attachment and migration (Karram et al. 2005). It regulates spreading of melanoma cells by recruiting and activating a signalling cascade through CDC42, ACK1 and p130cas (Eisenmann et al. 1999). It enhances FAK and ERK activation (Yang et al. 2004).